These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1524799)

  • 1. Cyclooxygenase products are not involved in the protection against myocardial infarction afforded by preconditioning in rabbit. Cyclooxygenase pathway's involvement in preconditioning.
    Liu GS; Stanley AW; Downey J
    Am J Cardiovasc Pathol; 1992; 4(2):157-64. PubMed ID: 1524799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart.
    Wang P; Gallagher KP; Downey JM; Cohen MV
    J Mol Cell Cardiol; 1996 Mar; 28(3):579-88. PubMed ID: 9011641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
    Faghihi M; Mirershadi F; Dehpour AR; Bazargan M
    Eur J Pharmacol; 2008 Nov; 597(1-3):57-63. PubMed ID: 18789320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
    Schwartz LM; Sebbag L; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global myocardial ischemia protects the myocardium from subsequent regional ischemia.
    Walker DM; Walker JM; Yellon DM
    Cardioscience; 1993 Dec; 4(4):263-6. PubMed ID: 8298068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart.
    Weinbrenner C; Schulze F; Sárváry L; Strasser RH
    Cardiovasc Res; 2004 Feb; 61(3):591-9. PubMed ID: 14962489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protection.
    Alkhulaifi AM; Pugsley WB; Yellon DM
    Cardioscience; 1993 Sep; 4(3):163-9. PubMed ID: 8400024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide protects against ischemia-reperfusion injury in rabbit hearts in vivo.
    Zhang WW; Hasaniya NW; Premaratne S; McNamara JJ
    Vasc Endovascular Surg; 2008; 42(3):263-7. PubMed ID: 18319356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts.
    Diaz RJ; Wilson GJ
    J Mol Cell Cardiol; 1997 Jan; 29(1):129-39. PubMed ID: 9040028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection.
    Goto M; Cohen MV; van Wylen DG; Downey JM
    J Mol Cell Cardiol; 1996 Mar; 28(3):447-54. PubMed ID: 9011628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium.
    Baines CP; Goto M; Downey JM
    J Mol Cell Cardiol; 1997 Jan; 29(1):207-16. PubMed ID: 9040035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The re-introduction of ischemic preconditioning is able to protect myocardium after repeated long reperfusion intervals.
    Iliodromitis EK; Kremastinos DT; Bouris I; Papadopoulos C; Paraskevaidis IA; Yellon DM
    Cardioscience; 1994 Dec; 5(4):277-81. PubMed ID: 7742487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of infarction in cynomolgus monkeys: preconditioning and postconditioning.
    Yang XM; Liu Y; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
    Basic Res Cardiol; 2010 Jan; 105(1):119-28. PubMed ID: 19669077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism.
    Thornton JD; Liu GS; Downey JM
    J Mol Cell Cardiol; 1993 Mar; 25(3):311-20. PubMed ID: 8510172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.
    Lochner A; Genade S; Moolman JA
    Basic Res Cardiol; 2003 Sep; 98(5):337-46. PubMed ID: 12955407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart.
    Bugge E; Ytrehus K
    J Mol Cell Cardiol; 1996 Dec; 28(12):2333-41. PubMed ID: 9004150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart.
    McCully JD; Uematsu M; Parker RA; Levitsky S
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):154-62. PubMed ID: 9671910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model.
    Leprán I; Pollesello P; Vajda S; Varró A; Papp JG
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):148-52. PubMed ID: 17086092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.